LONDON, Sept 25 (Reuters) - Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's ...

Merck & Co Inc. (MRK) on Wednesday said its Phase 3 KEYFORM-007 study evaluating the company's drug candidate favezelimab in ...

Merck & Co.’s said a late-stage trial of its blockbuster cancer drug Keytruda in combination with favezelimab failed to meet ...

(Reuters) -Merck said on Wednesday its therapy did not meet the main goal of a late-stage trial evaluating it in patients ...

Merck & Co.'s stock (MRK) fell 0.5% premarket Wednesday, after the drug company said a late-stage trial of its blockbuster cancer drug Keytruda in combination with favezelimab failed to meet the main ...

The Global Anti-Infective Agents market was valued at approximately USD 136.9 billion in 2023 and is projected to experience a modest growth rate with a CAGR of 1.2% over the forecast period from 2024 ...

The observed lower mortality with remdesivir plus dexamethasone in patients on IMV/ECMO "further supports the growing ...

UCI researchers have uncovered a striking correlation between internet searches for ADHD medications and actual prescription rates during the COVID-19 pandemic.

Surrogates faced a high risk of pregnancy and postpartum complications. (Annals of Internal Medicine) Antihypertensive ...

TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribetm RNA Polymerase, a novel enzyme that reduces double-stranded RNA (dsRNA) in mRNA ...

Non-muscle-invasive bladder cancer (NMIBC) is a type of bladder cancer where the tumor remains confined to the bladder's ...

The medical device/technology subsectors lagged on concerns that pent-up demand from COVID-19 could wane in the second half ... approval for its breakthrough gene therapy, Elevidys, but the drug was ...